Treating Addictions to Amphetamines, with Psilocybin

Joshua Woolley, University of California San Francisco

The mental health epidemic, including substance use disorders and addictions, is a global issue. Innovations in the range of medicines currently used in conjunction with psychotherapy have had little to no progress over the last two decades, however, the use of psychedelic therapy changed this paradigm. With increased preclinical research and clinical trials illustrating the beneficial effects of first-generation psychedelics, a wave of second-generation therapeutics is now emerging. In this video, you will hear from Dr. Josh Woolley, Associate Professor in Residence in the Department of Psychiatry and Behavioral Sciences at the University of California, San Francisco (UCSF) as well as a staff psychiatrist in Mental Health at the San Francisco Veterans Affairs Medical Center (SFVAMC).

Watch the full symposium here https://bit.ly/3cXs0mV



#CNSatCRL #NeuroscienceResearch